| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
William Arsani is a Director at DSGN. Recent filings cover 5 purchases and 3 sales. Those positions are worth an estimated $38.8M at current prices.
Our model assigns William Arsani a middling insider score of 55/100, based on 7 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +19.3%.
William Arsani's largest disclosed position is in DSGN as Director, worth about $38.8M. Net of sales, the recent Form 4 record there shows accumulation of 1,622,499 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | DSGN Design Therapeutics, Inc. | Director | Sell | 562,627 | $5.25 | $2,953,791.75 | -13.3% | +43.2% | - | |
| Aug 9, 2024 | DSGN Design Therapeutics, Inc. | Director | Sell | 814,874 | $4.25 | $3,463,214.50 | -100% | +36.6% | +0.9% | |
| Aug 29, 2023 | DSGN Design Therapeutics, Inc. | Director | Buy | 2,235,000 | $2.40 | $5,373,650.00 | +123.8% | -5.2% | +103.9% | |
| Mar 21, 2022 | DSGN Design Therapeutics, Inc. | Director | Buy | 25,000 | $18.99 | $474,680.00 | +0.9% | -19.2% | -66.4% | |
| Aug 31, 2021 | DSGN Design Therapeutics, Inc. | Director | Buy | 40,000 | $15.45 | $618,000.00 | +1.5% | +13.1% | +28.9% | |
| Mar 30, 2021 | DSGN Design Therapeutics, Inc. | Director | Buy | 700,000 | $20.00 | $14,000,000.00 | +34.4% | -22.5% | -45.8% |